Q. What is the size of Liquid Biopsy Market ?

The global liquid biopsy market is projected to reach USD 35.3 billion by 2033, growing at a CAGR of 13.1%

Q. What are the major growth factors of Liquid Biopsy Market?

The market is driven by the rising incidence and prevalence of cancer and the increasing preference for non-invasive treatment procedures.

Q. What is the total market value of liquid biopsy market report ?

The global liquid biopsy market size reached USD 10.3 billion in 2023 and is predicted to reach USD 35.3 billion by 2033.

Q. Which region will lead the global liquid biopsy market?

North America dominated the global liquid biopsy market in 2022 and will lead the market in near future.

Q. Who are the prominent key players in the Liquid Biopsy Market?

Qiagen N.V., Myriad Genetics Inc., BIOCEPT Inc., Guardant Health, Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Genomic Health, Inc., Bio-Rad Laboratories, Inc., Angle plc, Oncimmune are some of the prominent key players in the Liquid Biopsy Market.

Global Liquid Biopsy Market By Product Type (Instruments, Consumables Kits and Reagents, Software and Services) By Biomarker Type (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Extracellular Vesicles (EVs), Other Biomarker Types) By Technology (Multi-gene-parallel Analysis (NGS) and Single Gene Analysis (PCR Microarrays)) by Application (Cancer, Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Gastrointestinal Cancer, Reproductive Health and Other Applications) By End-use (Hospitals and Laboratories, Specialty Clinics, Academic and Research Centers Other End-Uses) By Clinical Application (Therapy Selection, Treatment Monitoring, Early Cancer Screening, Recurrence Monitoring and Other Clinical Applications) and forecast 2024-2033

Published date: Jan 2024
Report ID: 28756
Number of Pages: 271
Format:

- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Taxonomy
  - 1.3. Research Scope
  - 1.4. Key Analysis
  - 1.5. Key Findings by Major Segments
  - 1.6. Top strategies by Major Players
- 2. Global Liquid Biopsy Overview
  - 2.1. Liquid Biopsy Dynamics
    2.1.1. Drivers
    2.1.2. Opportunities
    2.1.3. Restraints
    2.1.4. Challenges
  - 2.2. Macro-economic Factors
  - 2.3. Regulatory Framework
  - 2.4. Market Investment Feasibility Index
  - 2.5. PEST Analysis
  - 2.6. PORTER’S Five Force Analysis
  - 2.7. Drivers & Restraints Impact Analysis
  - 2.8. Industry Chain Analysis
  - 2.9. Cost Structure Analysis
  - 2.10. Marketing Strategy
  - 2.11. Russia-Ukraine War Impact Analysis
  - 2.12. Opportunity Map Analysis
  - 2.13. Market Competition Scenario Analysis
  - 2.14. Product Life Cycle Analysis
  - 2.15. Opportunity Orbits
  - 2.16. Manufacturer Intensity Map
  - 2.17. Major Companies sales by Value & Volume
- 3. Global Liquid Biopsy Analysis, Opportunity and Forecast, 2016-2032
  - 3.1. Global Liquid Biopsy Analysis, 2016-2021
  - 3.2. Global Liquid Biopsy Opportunity and Forecast, 2023-2032
  - 3.3. Global Liquid Biopsy Analysis, Opportunity and Forecast, By Technology, 2016-2032
    3.3.1. Global Liquid Biopsy Analysis by Technology: Introduction
    3.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Technology, 2016-2032
    3.3.3. Single Gene Analysis (PCR Microarrays)
    3.3.3.1. Single Gene Analysis (PCR Microarrays)1
    3.3.3.2. Single Gene Analysis (PCR Microarrays)2
    3.3.4. Multi-gene-parallel Analysis (NGS)
  - 3.4. Global Liquid Biopsy Analysis, Opportunity and Forecast, By Biomarker, 2016-2032
    3.4.1. Global Liquid Biopsy Analysis by Biomarker: Introduction
    3.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Biomarker, 2016-2032
    3.4.3. Circulating Nucleic Acid
    3.4.4. Exosomes/Microvesicles
  - 3.5. Global Liquid Biopsy Analysis, Opportunity and Forecast, By Sample, 2016-2032
    3.5.1. Global Liquid Biopsy Analysis by Sample: Introduction
    3.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Sample, 2016-2032
    3.5.3. Blood Sample Based
    3.5.4. Other Samples
- 4. North America Liquid Biopsy Analysis, Opportunity and Forecast, 2016-2032
  - 4.1. North America Liquid Biopsy Analysis, 2016-2021
  - 4.2. North America Liquid Biopsy Opportunity and Forecast, 2023-2032
  - 4.3. North America Liquid Biopsy Analysis, Opportunity and Forecast, By Technology, 2016-2032
    4.3.1. North America Liquid Biopsy Analysis by Technology: Introduction
    4.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Technology, 2016-2032
    4.3.3. Single Gene Analysis (PCR Microarrays)
    4.3.3.1. Single Gene Analysis (PCR Microarrays)1
    4.3.3.2. Single Gene Analysis (PCR Microarrays)2
    4.3.4. Multi-gene-parallel Analysis (NGS)
  - 4.4. North America Liquid Biopsy Analysis, Opportunity and Forecast, By Biomarker, 2016-2032
    4.4.1. North America Liquid Biopsy Analysis by Biomarker: Introduction
    4.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Biomarker, 2016-2032
    4.4.3. Circulating Nucleic Acid
    4.4.4. Exosomes/Microvesicles
  - 4.5. North America Liquid Biopsy Analysis, Opportunity and Forecast, By Sample, 2016-2032
    4.5.1. North America Liquid Biopsy Analysis by Sample: Introduction
    4.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Sample, 2016-2032
    4.5.3. Blood Sample Based
    4.5.4. Other Samples
  - 4.6. North America Liquid Biopsy Analysis, Opportunity and Forecast, By Country , 2016-2032
    4.6.1. North America Liquid Biopsy Analysis by Country : Introduction
    4.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    4.6.2.1. U.S.
    4.6.2.2. Canada
    4.6.2.3. Mexico
- 5. Europe Liquid Biopsy Analysis, Opportunity and Forecast, 2016-2032
  - 5.1. Europe Liquid Biopsy Analysis, 2016-2021
  - 5.2. Europe Liquid Biopsy Opportunity and Forecast, 2023-2032
  - 5.3. Europe Liquid Biopsy Analysis, Opportunity and Forecast, By Technology, 2016-2032
    5.3.1. Europe Liquid Biopsy Analysis by Technology: Introduction
    5.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Technology, 2016-2032
    5.3.3. Single Gene Analysis (PCR Microarrays)
    5.3.3.1. Single Gene Analysis (PCR Microarrays)1
    5.3.3.2. Single Gene Analysis (PCR Microarrays)2
    5.3.4. Multi-gene-parallel Analysis (NGS)
  - 5.4. Europe Liquid Biopsy Analysis, Opportunity and Forecast, By Biomarker, 2016-2032
    5.4.1. Europe Liquid Biopsy Analysis by Biomarker: Introduction
    5.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Biomarker, 2016-2032
    5.4.3. Circulating Nucleic Acid
    5.4.4. Exosomes/Microvesicles
  - 5.5. Europe Liquid Biopsy Analysis, Opportunity and Forecast, By Sample, 2016-2032
    5.5.1. Europe Liquid Biopsy Analysis by Sample: Introduction
    5.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Sample, 2016-2032
    5.5.3. Blood Sample Based
    5.5.4. Other Samples
  - 5.6. Europe Liquid Biopsy Analysis, Opportunity and Forecast, By Country , 2016-2032
    5.6.1. Europe Liquid Biopsy Analysis by Country : Introduction
    5.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    5.6.2.1. U.K.
    5.6.2.2. Germany
    5.6.2.3. France
    5.6.2.4. Spain
    5.6.2.5. Italy
    5.6.2.6. Russia
    5.6.2.7. Rest of Europe
- 6. Asia-Pacific Liquid Biopsy Analysis, Opportunity and Forecast, 2016-2032
  - 6.1. Asia-Pacific Liquid Biopsy Analysis, 2016-2021
  - 6.2. Asia-Pacific Liquid Biopsy Opportunity and Forecast, 2023-2032
  - 6.3. Asia-Pacific Liquid Biopsy Analysis, Opportunity and Forecast, By Technology, 2016-2032
    6.3.1. Asia-Pacific Liquid Biopsy Analysis by Technology: Introduction
    6.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Technology, 2016-2032
    6.3.3. Single Gene Analysis (PCR Microarrays)
    6.3.3.1. Single Gene Analysis (PCR Microarrays)1
    6.3.3.2. Single Gene Analysis (PCR Microarrays)2
    6.3.4. Multi-gene-parallel Analysis (NGS)
  - 6.4. Asia-Pacific Liquid Biopsy Analysis, Opportunity and Forecast, By Biomarker, 2016-2032
    6.4.1. Asia-Pacific Liquid Biopsy Analysis by Biomarker: Introduction
    6.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Biomarker, 2016-2032
    6.4.3. Circulating Nucleic Acid
    6.4.4. Exosomes/Microvesicles
  - 6.5. Asia-Pacific Liquid Biopsy Analysis, Opportunity and Forecast, By Sample, 2016-2032
    6.5.1. Asia-Pacific Liquid Biopsy Analysis by Sample: Introduction
    6.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Sample, 2016-2032
    6.5.3. Blood Sample Based
    6.5.4. Other Samples
  - 6.6. Asia-Pacific Liquid Biopsy Analysis, Opportunity and Forecast, By Country , 2016-2032
    6.6.1. Asia-Pacific Liquid Biopsy Analysis by Country : Introduction
    6.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    6.6.2.1. China
    6.6.2.2. Japan
    6.6.2.3. South Korea
    6.6.2.4. India
    6.6.2.5. Rest of Asia-Pacific
- 7. South America Liquid Biopsy Analysis, Opportunity and Forecast, 2016-2032
  - 7.1. South America Liquid Biopsy Analysis, 2016-2021
  - 7.2. South America Liquid Biopsy Opportunity and Forecast, 2023-2032
  - 7.3. South America Liquid Biopsy Analysis, Opportunity and Forecast, By Technology, 2016-2032
    7.3.1. South America Liquid Biopsy Analysis by Technology: Introduction
    7.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Technology, 2016-2032
    7.3.3. Single Gene Analysis (PCR Microarrays)
    7.3.3.1. Single Gene Analysis (PCR Microarrays)1
    7.3.3.2. Single Gene Analysis (PCR Microarrays)2
    7.3.4. Multi-gene-parallel Analysis (NGS)
  - 7.4. South America Liquid Biopsy Analysis, Opportunity and Forecast, By Biomarker, 2016-2032
    7.4.1. South America Liquid Biopsy Analysis by Biomarker: Introduction
    7.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Biomarker, 2016-2032
    7.4.3. Circulating Nucleic Acid
    7.4.4. Exosomes/Microvesicles
  - 7.5. South America Liquid Biopsy Analysis, Opportunity and Forecast, By Sample, 2016-2032
    7.5.1. South America Liquid Biopsy Analysis by Sample: Introduction
    7.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Sample, 2016-2032
    7.5.3. Blood Sample Based
    7.5.4. Other Samples
  - 7.6. South America Liquid Biopsy Analysis, Opportunity and Forecast, By Country , 2016-2032
    7.6.1. South America Liquid Biopsy Analysis by Country : Introduction
    7.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    7.6.2.1. Brazil
    7.6.2.2. Argentina
    7.6.2.3. Rest of South America
- 8. Middle East and Africa Liquid Biopsy Analysis, Opportunity and Forecast, 2016-2032
  - 8.1. Middle East and Africa Liquid Biopsy Analysis, 2016-2021
  - 8.2. Middle East and Africa Liquid Biopsy Opportunity and Forecast, 2023-2032
  - 8.3. Middle East and Africa Liquid Biopsy Analysis, Opportunity and Forecast, By Technology, 2016-2032
    8.3.1. Middle East and Africa Liquid Biopsy Analysis by Technology: Introduction
    8.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Technology, 2016-2032
    8.3.3. Single Gene Analysis (PCR Microarrays)
    8.3.3.1. Single Gene Analysis (PCR Microarrays)1
    8.3.3.2. Single Gene Analysis (PCR Microarrays)2
    8.3.4. Multi-gene-parallel Analysis (NGS)
  - 8.4. Middle East and Africa Liquid Biopsy Analysis, Opportunity and Forecast, By Biomarker, 2016-2032
    8.4.1. Middle East and Africa Liquid Biopsy Analysis by Biomarker: Introduction
    8.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Biomarker, 2016-2032
    8.4.3. Circulating Nucleic Acid
    8.4.4. Exosomes/Microvesicles
  - 8.5. Middle East and Africa Liquid Biopsy Analysis, Opportunity and Forecast, By Sample, 2016-2032
    8.5.1. Middle East and Africa Liquid Biopsy Analysis by Sample: Introduction
    8.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Sample, 2016-2032
    8.5.3. Blood Sample Based
    8.5.4. Other Samples
  - 8.6. Middle East and Africa Liquid Biopsy Analysis, Opportunity and Forecast, By Country , 2016-2032
    8.6.1. Middle East and Africa Liquid Biopsy Analysis by Country : Introduction
    8.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    8.6.2.1. GCC
    8.6.2.2. Israel
    8.6.2.3. South Africa
    8.6.2.4. Rest of MEA
- 9. Global Liquid Biopsy Analysis, Opportunity and Forecast, By Region , 2016-2032
  - 9.1. Global Liquid Biopsy Analysis by Region : Introduction
  - 9.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Region , 2016-2032
    9.2.1. North America
    9.2.2. Europe
    9.2.3. Asia-Pacific
    9.2.4. South America
    9.2.5. Middle East and Africa
- 10. Global Liquid Biopsy Competitive Landscape, Market Share Analysis, and Company Profiles
  - 10.1. Market Share Analysis
  - 10.2. Company Profiles
  - 10.3. QIAGEN
    10.3.1. Company Overview
    10.3.2. Financial Highlights
    10.3.3. Product Portfolio
    10.3.4. SWOT Analysis
    10.3.5. Key Strategies and Developments
  - 10.4. Myriad Genetics, Inc.
    10.4.1. Company Overview
    10.4.2. Financial Highlights
    10.4.3. Product Portfolio
    10.4.4. SWOT Analysis
    10.4.5. Key Strategies and Developments
  - 10.5. BIOCEPT, Inc.
    10.5.1. Company Overview
    10.5.2. Financial Highlights
    10.5.3. Product Portfolio
    10.5.4. SWOT Analysis
    10.5.5. Key Strategies and Developments
  - 10.6. Guardant Health, Inc.
    10.6.1. Company Overview
    10.6.2. Financial Highlights
    10.6.3. Product Portfolio
    10.6.4. SWOT Analysis
    10.6.5. Key Strategies and Developments
  - 10.7. F. Hoffmann-La Roche Ltd.
    10.7.1. Company Overview
    10.7.2. Financial Highlights
    10.7.3. Product Portfolio
    10.7.4. SWOT Analysis
    10.7.5. Key Strategies and Developments
  - 10.8. Illumina, Inc.
    10.8.1. Company Overview
    10.8.2. Financial Highlights
    10.8.3. Product Portfolio
    10.8.4. SWOT Analysis
    10.8.5. Key Strategies and Developments
  - 10.9. Angle plc
    10.9.1. Company Overview
    10.9.2. Financial Highlights
    10.9.3. Product Portfolio
    10.9.4. SWOT Analysis
    10.9.5. Key Strategies and Developments
  - 10.10. Oncimmune
    10.10.1. Company Overview
    10.10.2. Financial Highlights
    10.10.3. Product Portfolio
    10.10.4. SWOT Analysis
    10.10.5. Key Strategies and Developments
  - 10.11. Other Key Players
    10.11.1. Company Overview
    10.11.2. Financial Highlights
    10.11.3. Product Portfolio
    10.11.4. SWOT Analysis
    10.11.5. Key Strategies and Developments
- 11. Assumptions and Acronyms
- 12. Research Methodology
- 13. Contact
- List of Figures
  - Figure 1: Global Liquid Biopsy Revenue (US$ Mn) Market Share by Technology in 2022
  - Figure 2: Global Liquid Biopsy Market Attractiveness Analysis by Technology, 2016-2032
  - Figure 3: Global Liquid Biopsy Revenue (US$ Mn) Market Share by Biomarkerin 2022
  - Figure 4: Global Liquid Biopsy Market Attractiveness Analysis by Biomarker, 2016-2032
  - Figure 5: Global Liquid Biopsy Revenue (US$ Mn) Market Share by Samplein 2022
  - Figure 6: Global Liquid Biopsy Market Attractiveness Analysis by Sample, 2016-2032
  - Figure 7: Global Liquid Biopsy Revenue (US$ Mn) Market Share by Region in 2022
  - Figure 8: Global Liquid Biopsy Market Attractiveness Analysis by Region, 2016-2032
  - Figure 9: Global Liquid Biopsy Market Revenue (US$ Mn) (2016-2032)
  - Figure 10: Global Liquid Biopsy Market Revenue (US$ Mn) Comparison by Region (2016-2032)
  - Figure 11: Global Liquid Biopsy Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
  - Figure 12: Global Liquid Biopsy Market Revenue (US$ Mn) Comparison by Biomarker (2016-2032)
  - Figure 13: Global Liquid Biopsy Market Revenue (US$ Mn) Comparison by Sample (2016-2032)
  - Figure 14: Global Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
  - Figure 15: Global Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
  - Figure 16: Global Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Biomarker (2016-2032)
  - Figure 17: Global Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Sample (2016-2032)
  - Figure 18: Global Liquid Biopsy Market Share Comparison by Region (2016-2032)
  - Figure 19: Global Liquid Biopsy Market Share Comparison by Technology (2016-2032)
  - Figure 20: Global Liquid Biopsy Market Share Comparison by Biomarker (2016-2032)
  - Figure 21: Global Liquid Biopsy Market Share Comparison by Sample (2016-2032)
  - Figure 22: North America Liquid Biopsy Revenue (US$ Mn) Market Share by Technologyin 2022
  - Figure 23: North America Liquid Biopsy Market Attractiveness Analysis by Technology, 2016-2032
  - Figure 24: North America Liquid Biopsy Revenue (US$ Mn) Market Share by Biomarkerin 2022
  - Figure 25: North America Liquid Biopsy Market Attractiveness Analysis by Biomarker, 2016-2032
  - Figure 26: North America Liquid Biopsy Revenue (US$ Mn) Market Share by Samplein 2022
  - Figure 27: North America Liquid Biopsy Market Attractiveness Analysis by Sample, 2016-2032
  - Figure 28: North America Liquid Biopsy Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 29: North America Liquid Biopsy Market Attractiveness Analysis by Country, 2016-2032
  - Figure 30: North America Liquid Biopsy Market Revenue (US$ Mn) (2016-2032)
  - Figure 31: North America Liquid Biopsy Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 32: North America Liquid Biopsy Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
  - Figure 33: North America Liquid Biopsy Market Revenue (US$ Mn) Comparison by Biomarker (2016-2032)
  - Figure 34: North America Liquid Biopsy Market Revenue (US$ Mn) Comparison by Sample (2016-2032)
  - Figure 35: North America Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 36: North America Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
  - Figure 37: North America Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Biomarker (2016-2032)
  - Figure 38: North America Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Sample (2016-2032)
  - Figure 39: North America Liquid Biopsy Market Share Comparison by Country (2016-2032)
  - Figure 40: North America Liquid Biopsy Market Share Comparison by Technology (2016-2032)
  - Figure 41: North America Liquid Biopsy Market Share Comparison by Biomarker (2016-2032)
  - Figure 42: North America Liquid Biopsy Market Share Comparison by Sample (2016-2032)
  - Figure 43: Europe Liquid Biopsy Revenue (US$ Mn) Market Share by Technologyin 2022
  - Figure 44: Europe Liquid Biopsy Market Attractiveness Analysis by Technology, 2016-2032
  - Figure 45: Europe Liquid Biopsy Revenue (US$ Mn) Market Share by Biomarkerin 2022
  - Figure 46: Europe Liquid Biopsy Market Attractiveness Analysis by Biomarker, 2016-2032
  - Figure 47: Europe Liquid Biopsy Revenue (US$ Mn) Market Share by Samplein 2022
  - Figure 48: Europe Liquid Biopsy Market Attractiveness Analysis by Sample, 2016-2032
  - Figure 49: Europe Liquid Biopsy Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 50: Europe Liquid Biopsy Market Attractiveness Analysis by Country, 2016-2032
  - Figure 51: Europe Liquid Biopsy Market Revenue (US$ Mn) (2016-2032)
  - Figure 52: Europe Liquid Biopsy Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 53: Europe Liquid Biopsy Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
  - Figure 54: Europe Liquid Biopsy Market Revenue (US$ Mn) Comparison by Biomarker (2016-2032)
  - Figure 55: Europe Liquid Biopsy Market Revenue (US$ Mn) Comparison by Sample (2016-2032)
  - Figure 56: Europe Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 57: Europe Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
  - Figure 58: Europe Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Biomarker (2016-2032)
  - Figure 59: Europe Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Sample (2016-2032)
  - Figure 60: Europe Liquid Biopsy Market Share Comparison by Country (2016-2032)
  - Figure 61: Europe Liquid Biopsy Market Share Comparison by Technology (2016-2032)
  - Figure 62: Europe Liquid Biopsy Market Share Comparison by Biomarker (2016-2032)
  - Figure 63: Europe Liquid Biopsy Market Share Comparison by Sample (2016-2032)
  - Figure 64: Asia-Pacific Liquid Biopsy Revenue (US$ Mn) Market Share by Technologyin 2022
  - Figure 65: Asia-Pacific Liquid Biopsy Market Attractiveness Analysis by Technology, 2016-2032
  - Figure 66: Asia-Pacific Liquid Biopsy Revenue (US$ Mn) Market Share by Biomarkerin 2022
  - Figure 67: Asia-Pacific Liquid Biopsy Market Attractiveness Analysis by Biomarker, 2016-2032
  - Figure 68: Asia-Pacific Liquid Biopsy Revenue (US$ Mn) Market Share by Samplein 2022
  - Figure 69: Asia-Pacific Liquid Biopsy Market Attractiveness Analysis by Sample, 2016-2032
  - Figure 70: Asia-Pacific Liquid Biopsy Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 71: Asia-Pacific Liquid Biopsy Market Attractiveness Analysis by Country, 2016-2032
  - Figure 72: Asia-Pacific Liquid Biopsy Market Revenue (US$ Mn) (2016-2032)
  - Figure 73: Asia-Pacific Liquid Biopsy Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 74: Asia-Pacific Liquid Biopsy Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
  - Figure 75: Asia-Pacific Liquid Biopsy Market Revenue (US$ Mn) Comparison by Biomarker (2016-2032)
  - Figure 76: Asia-Pacific Liquid Biopsy Market Revenue (US$ Mn) Comparison by Sample (2016-2032)
  - Figure 77: Asia-Pacific Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 78: Asia-Pacific Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
  - Figure 79: Asia-Pacific Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Biomarker (2016-2032)
  - Figure 80: Asia-Pacific Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Sample (2016-2032)
  - Figure 81: Asia-Pacific Liquid Biopsy Market Share Comparison by Country (2016-2032)
  - Figure 82: Asia-Pacific Liquid Biopsy Market Share Comparison by Technology (2016-2032)
  - Figure 83: Asia-Pacific Liquid Biopsy Market Share Comparison by Biomarker (2016-2032)
  - Figure 84: Asia-Pacific Liquid Biopsy Market Share Comparison by Sample (2016-2032)
  - Figure 85: South America Liquid Biopsy Revenue (US$ Mn) Market Share by Technologyin 2022
  - Figure 86: South America Liquid Biopsy Market Attractiveness Analysis by Technology, 2016-2032
  - Figure 87: South America Liquid Biopsy Revenue (US$ Mn) Market Share by Biomarkerin 2022
  - Figure 88: South America Liquid Biopsy Market Attractiveness Analysis by Biomarker, 2016-2032
  - Figure 89: South America Liquid Biopsy Revenue (US$ Mn) Market Share by Samplein 2022
  - Figure 90: South America Liquid Biopsy Market Attractiveness Analysis by Sample, 2016-2032
  - Figure 91: South America Liquid Biopsy Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 92: South America Liquid Biopsy Market Attractiveness Analysis by Country, 2016-2032
  - Figure 93: South America Liquid Biopsy Market Revenue (US$ Mn) (2016-2032)
  - Figure 94: South America Liquid Biopsy Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 95: South America Liquid Biopsy Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
  - Figure 96: South America Liquid Biopsy Market Revenue (US$ Mn) Comparison by Biomarker (2016-2032)
  - Figure 97: South America Liquid Biopsy Market Revenue (US$ Mn) Comparison by Sample (2016-2032)
  - Figure 98: South America Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 99: South America Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
  - Figure 100: South America Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Biomarker (2016-2032)
  - Figure 101: South America Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Sample (2016-2032)
  - Figure 102: South America Liquid Biopsy Market Share Comparison by Country (2016-2032)
  - Figure 103: South America Liquid Biopsy Market Share Comparison by Technology (2016-2032)
  - Figure 104: South America Liquid Biopsy Market Share Comparison by Biomarker (2016-2032)
  - Figure 105: South America Liquid Biopsy Market Share Comparison by Sample (2016-2032)
  - Figure 106: Middle East and Africa Liquid Biopsy Revenue (US$ Mn) Market Share by Technology in 2022
  - Figure 107: Middle East and Africa Liquid Biopsy Market Attractiveness Analysis by Technology, 2016-2032
  - Figure 108: Middle East and Africa Liquid Biopsy Revenue (US$ Mn) Market Share by Biomarkerin 2022
  - Figure 109: Middle East and Africa Liquid Biopsy Market Attractiveness Analysis by Biomarker, 2016-2032
  - Figure 110: Middle East and Africa Liquid Biopsy Revenue (US$ Mn) Market Share by Samplein 2022
  - Figure 111: Middle East and Africa Liquid Biopsy Market Attractiveness Analysis by Sample, 2016-2032
  - Figure 112: Middle East and Africa Liquid Biopsy Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 113: Middle East and Africa Liquid Biopsy Market Attractiveness Analysis by Country, 2016-2032
  - Figure 114: Middle East and Africa Liquid Biopsy Market Revenue (US$ Mn) (2016-2032)
  - Figure 115: Middle East and Africa Liquid Biopsy Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 116: Middle East and Africa Liquid Biopsy Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
  - Figure 117: Middle East and Africa Liquid Biopsy Market Revenue (US$ Mn) Comparison by Biomarker (2016-2032)
  - Figure 118: Middle East and Africa Liquid Biopsy Market Revenue (US$ Mn) Comparison by Sample (2016-2032)
  - Figure 119: Middle East and Africa Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 120: Middle East and Africa Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
  - Figure 121: Middle East and Africa Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Biomarker (2016-2032)
  - Figure 122: Middle East and Africa Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Sample (2016-2032)
  - Figure 123: Middle East and Africa Liquid Biopsy Market Share Comparison by Country (2016-2032)
  - Figure 124: Middle East and Africa Liquid Biopsy Market Share Comparison by Technology (2016-2032)
  - Figure 125: Middle East and Africa Liquid Biopsy Market Share Comparison by Biomarker (2016-2032)
  - Figure 126: Middle East and Africa Liquid Biopsy Market Share Comparison by Sample (2016-2032)
- List of Tables
  - Table 1: Global Liquid Biopsy Market Comparison by Technology (2016-2032)
  - Table 2: Global Liquid Biopsy Market Comparison by Biomarker (2016-2032)
  - Table 3: Global Liquid Biopsy Market Comparison by Sample (2016-2032)
  - Table 4: Global Liquid Biopsy Revenue (US$ Mn) Comparison by Region (2016-2032)
  - Table 5: Global Liquid Biopsy Market Revenue (US$ Mn) (2016-2032)
  - Table 6: Global Liquid Biopsy Market Revenue (US$ Mn) Comparison by Region (2016-2032)
  - Table 7: Global Liquid Biopsy Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
  - Table 8: Global Liquid Biopsy Market Revenue (US$ Mn) Comparison by Biomarker (2016-2032)
  - Table 9: Global Liquid Biopsy Market Revenue (US$ Mn) Comparison by Sample (2016-2032)
  - Table 10: Global Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
  - Table 11: Global Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
  - Table 12: Global Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Biomarker (2016-2032)
  - Table 13: Global Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Sample (2016-2032)
  - Table 14: Global Liquid Biopsy Market Share Comparison by Region (2016-2032)
  - Table 15: Global Liquid Biopsy Market Share Comparison by Technology (2016-2032)
  - Table 16: Global Liquid Biopsy Market Share Comparison by Biomarker (2016-2032)
  - Table 17: Global Liquid Biopsy Market Share Comparison by Sample (2016-2032)
  - Table 18: North America Liquid Biopsy Market Comparison by Biomarker (2016-2032)
  - Table 19: North America Liquid Biopsy Market Comparison by Sample (2016-2032)
  - Table 20: North America Liquid Biopsy Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 21: North America Liquid Biopsy Market Revenue (US$ Mn) (2016-2032)
  - Table 22: North America Liquid Biopsy Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 23: North America Liquid Biopsy Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
  - Table 24: North America Liquid Biopsy Market Revenue (US$ Mn) Comparison by Biomarker (2016-2032)
  - Table 25: North America Liquid Biopsy Market Revenue (US$ Mn) Comparison by Sample (2016-2032)
  - Table 26: North America Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 27: North America Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
  - Table 28: North America Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Biomarker (2016-2032)
  - Table 29: North America Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Sample (2016-2032)
  - Table 30: North America Liquid Biopsy Market Share Comparison by Country (2016-2032)
  - Table 31: North America Liquid Biopsy Market Share Comparison by Technology (2016-2032)
  - Table 32: North America Liquid Biopsy Market Share Comparison by Biomarker (2016-2032)
  - Table 33: North America Liquid Biopsy Market Share Comparison by Sample (2016-2032)
  - Table 34: Europe Liquid Biopsy Market Comparison by Technology (2016-2032)
  - Table 35: Europe Liquid Biopsy Market Comparison by Biomarker (2016-2032)
  - Table 36: Europe Liquid Biopsy Market Comparison by Sample (2016-2032)
  - Table 37: Europe Liquid Biopsy Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 38: Europe Liquid Biopsy Market Revenue (US$ Mn) (2016-2032)
  - Table 39: Europe Liquid Biopsy Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 40: Europe Liquid Biopsy Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
  - Table 41: Europe Liquid Biopsy Market Revenue (US$ Mn) Comparison by Biomarker (2016-2032)
  - Table 42: Europe Liquid Biopsy Market Revenue (US$ Mn) Comparison by Sample (2016-2032)
  - Table 43: Europe Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 44: Europe Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
  - Table 45: Europe Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Biomarker (2016-2032)
  - Table 46: Europe Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Sample (2016-2032)
  - Table 47: Europe Liquid Biopsy Market Share Comparison by Country (2016-2032)
  - Table 48: Europe Liquid Biopsy Market Share Comparison by Technology (2016-2032)
  - Table 49: Europe Liquid Biopsy Market Share Comparison by Biomarker (2016-2032)
  - Table 50: Europe Liquid Biopsy Market Share Comparison by Sample (2016-2032)
  - Table 51: Asia-Pacific Liquid Biopsy Market Comparison by Technology (2016-2032)
  - Table 52: Asia-Pacific Liquid Biopsy Market Comparison by Biomarker (2016-2032)
  - Table 53: Asia-Pacific Liquid Biopsy Market Comparison by Sample (2016-2032)
  - Table 54: Asia-Pacific Liquid Biopsy Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 55: Asia-Pacific Liquid Biopsy Market Revenue (US$ Mn) (2016-2032)
  - Table 56: Asia-Pacific Liquid Biopsy Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 57: Asia-Pacific Liquid Biopsy Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
  - Table 58: Asia-Pacific Liquid Biopsy Market Revenue (US$ Mn) Comparison by Biomarker (2016-2032)
  - Table 59: Asia-Pacific Liquid Biopsy Market Revenue (US$ Mn) Comparison by Sample (2016-2032)
  - Table 60: Asia-Pacific Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 61: Asia-Pacific Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
  - Table 62: Asia-Pacific Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Biomarker (2016-2032)
  - Table 63: Asia-Pacific Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Sample (2016-2032)
  - Table 64: Asia-Pacific Liquid Biopsy Market Share Comparison by Country (2016-2032)
  - Table 65: Asia-Pacific Liquid Biopsy Market Share Comparison by Technology (2016-2032)
  - Table 66: Asia-Pacific Liquid Biopsy Market Share Comparison by Biomarker (2016-2032)
  - Table 67: Asia-Pacific Liquid Biopsy Market Share Comparison by Sample (2016-2032)
  - Table 68: South America Liquid Biopsy Market Comparison by Technology (2016-2032)
  - Table 69: South America Liquid Biopsy Market Comparison by Biomarker (2016-2032)
  - Table 70: South America Liquid Biopsy Market Comparison by Sample (2016-2032)
  - Table 71: South America Liquid Biopsy Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 72: South America Liquid Biopsy Market Revenue (US$ Mn) (2016-2032)
  - Table 73: South America Liquid Biopsy Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 74: South America Liquid Biopsy Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
  - Table 75: South America Liquid Biopsy Market Revenue (US$ Mn) Comparison by Biomarker (2016-2032)
  - Table 76: South America Liquid Biopsy Market Revenue (US$ Mn) Comparison by Sample (2016-2032)
  - Table 77: South America Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 78: South America Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
  - Table 79: South America Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Biomarker (2016-2032)
  - Table 80: South America Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Sample (2016-2032)
  - Table 81: South America Liquid Biopsy Market Share Comparison by Country (2016-2032)
  - Table 82: South America Liquid Biopsy Market Share Comparison by Technology (2016-2032)
  - Table 83: South America Liquid Biopsy Market Share Comparison by Biomarker (2016-2032)
  - Table 84: South America Liquid Biopsy Market Share Comparison by Sample (2016-2032)
  - Table 85: Middle East and Africa Liquid Biopsy Market Comparison by Technology (2016-2032)
  - Table 86: Middle East and Africa Liquid Biopsy Market Comparison by Biomarker (2016-2032)
  - Table 87: Middle East and Africa Liquid Biopsy Market Comparison by Sample (2016-2032)
  - Table 88: Middle East and Africa Liquid Biopsy Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 89: Middle East and Africa Liquid Biopsy Market Revenue (US$ Mn) (2016-2032)
  - Table 90: Middle East and Africa Liquid Biopsy Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 91: Middle East and Africa Liquid Biopsy Market Revenue (US$ Mn) Comparison by Technology (2016-2032)
  - Table 92: Middle East and Africa Liquid Biopsy Market Revenue (US$ Mn) Comparison by Biomarker (2016-2032)
  - Table 93: Middle East and Africa Liquid Biopsy Market Revenue (US$ Mn) Comparison by Sample (2016-2032)
  - Table 94: Middle East and Africa Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 95: Middle East and Africa Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Technology (2016-2032)
  - Table 96: Middle East and Africa Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Biomarker (2016-2032)
  - Table 97: Middle East and Africa Liquid Biopsy Market Y-o-Y Growth Rate Comparison by Sample (2016-2032)
  - Table 98: Middle East and Africa Liquid Biopsy Market Share Comparison by Country (2016-2032)
  - Table 99: Middle East and Africa Liquid Biopsy Market Share Comparison by Technology (2016-2032)
  - Table 100: Middle East and Africa Liquid Biopsy Market Share Comparison by Biomarker (2016-2032)
  - Table 101: Middle East and Africa Liquid Biopsy Market Share Comparison by Sample (2016-2032)
- ANGLE plc
- Oncimmune
- Guardant Health, Inc.
- Myriad Genetics, Inc.
- Biocept, Inc.
- Lucence Health Inc.
- Freenome Holdings, Inc.
- F. Hoffmann-La Roche Ltd.
- QIAGEN NV Company Profile
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Epigenomics AG
- Other Key Players
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $4,599 $3,499 USD / per unit save 24%	Multi User $5,999 $4,299 USD / per unit save 28%	Corporate User $7,299 $4,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,499)	Buy Now ($ 4,299)	Buy Now ($ 4,999)